MarketCap
Facebook
X
TelegramGeschäftsbericht 2023
hinzugefügt 27.12.2025
MorphoSys AG EV/EBITDA 2011-2026 | MOR
EV/EBITDA Jährlich MorphoSys AG
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.591 | 150 | -38.6 | -53.1 | - | - | - | - | - | - | - |
Alle Zahlen in EUR-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 150 | -53.1 | 14.5 |
EV/EBITDA anderer Aktien in der Pharmaeinzelhändler
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Acorda Therapeutics
ACOR
|
0.777 | - | -24.86 % | $ 820 K |  USA |
 |
Acasti Pharma
ACST
|
1.8 | - | 4.01 % | $ 150 M |  Canada |
 |
ARCA biopharma
ABIO
|
1.84 | - | 1052.0 % | $ 415 M | USA |
 |
Albireo Pharma
ALBO
|
-3.38 | - | -0.23 % | $ 916 M | USA |
 |
Adagene
ADAG
|
-4.92 | $ 2.91 | 5.05 % | $ 164 M |  China |
 |
ANI Pharmaceuticals
ANIP
|
109 | $ 82.0 | 3.13 % | $ 1.58 B | USA |
 |
Aytu BioScience
AYTU
|
-1.92 | $ 2.58 | -1.53 % | $ 16.2 M | USA |
 |
Beam Therapeutics
BEAM
|
-11.7 | $ 29.29 | 0.93 % | $ 2.41 B | USA |
 |
Biogen
BIIB
|
12.7 | $ 176.18 | 0.77 % | $ 25.7 B | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
10.7 | - | - | $ 40.3 B | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-4.27 | - | - | $ 1.01 B | USA |
 |
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M |  France |
 |
BioNTech SE
BNTX
|
4.1 | $ 116.77 | 0.53 % | $ 27.2 B |  Germany |
 |
Midatech Pharma plc
MTP
|
0.796 | - | -18.52 % | $ 27.3 M |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.42 | - | -1.52 % | $ 24.7 M | USA |
 |
Alterity Therapeutics Limited
ATHE
|
-0.994 | $ 3.26 | -3.55 % | $ 7.84 B |  Australia |
 |
Akero Therapeutics
AKRO
|
-4.64 | - | - | $ 3.67 B | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-43.1 | $ 4.1 | -1.2 % | $ 8.92 B |  Israel |
 |
Catalyst Biosciences
CBIO
|
0.34 | $ 10.15 | -5.45 % | $ 668 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
0.298 | - | 3.16 % | $ 1.9 M | USA |
 |
AVROBIO
AVRO
|
0.957 | - | 1083.1 % | $ 745 M | USA |
 |
Cerus Corporation
CERS
|
-24.7 | $ 2.32 | -1.69 % | $ 428 M | USA |
 |
Aptose Biosciences
APTO
|
388 | - | -45.71 % | $ 1.2 M | Canada |
 |
Coherus BioSciences
CHRS
|
-4.11 | $ 2.33 | 5.19 % | $ 219 M | USA |
 |
Aravive
ARAV
|
-0.158 | - | -13.39 % | $ 1.45 M | USA |
 |
Brickell Biotech
BBI
|
0.668 | - | -5.38 % | $ 6.06 M | USA |
 |
Applied Molecular Transport
AMTI
|
-1.19 | - | - | $ 10.1 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
14 | - | - | - |  Russia |
 |
Ascendis Pharma A/S
ASND
|
-15.7 | $ 223.95 | 0.67 % | $ 5 B |  Danmark |
 |
Cellectis S.A.
CLLS
|
-1.37 | $ 3.99 | -1.72 % | $ 116 M | France |
 |
Athira Pharma
ATHA
|
-3.66 | - | - | $ 269 M | USA |
 |
Atreca
BCEL
|
-2.76 | - | -11.76 % | $ 5.79 M | USA |
 |
Arrowhead Pharmaceuticals
ARWR
|
-30.8 | $ 69.12 | 5.4 % | $ 9.25 B | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
7.16 | $ 24.58 | 1.57 % | $ 2.91 B | USA |
 |
Cardiff Oncology
CRDF
|
-8.15 | $ 1.62 | -0.31 % | $ 77.2 M | USA |
 |
Aeterna Zentaris
AEZS
|
4.4 | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
-1.85 | - | -10.17 % | $ 12.2 K | USA |
 |
Akouos
AKUS
|
-1.13 | - | 0.23 % | $ 488 M | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
1.13 | - | -9.72 % | $ 5.89 M | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
-12.7 | - | -15.15 % | $ 60.3 M | Britain |
 |
DBV Technologies S.A.
DBVT
|
-0.266 | $ 22.96 | -3.41 % | $ 2.23 B | France |
 |
Berkeley Lights
BLI
|
-16.9 | - | -7.31 % | $ 87 M | USA |
 |
Amneal Pharmaceuticals
AMRX
|
1.63 | $ 14.11 | 1.15 % | $ 4.36 B | USA |
 |
AIkido Pharma
AIKI
|
-45.5 | - | 1.93 % | $ 17.4 M | USA |
 |
Bellerophon Therapeutics
BLPH
|
0.0235 | - | -74.18 % | $ 955 K | USA |
 |
CureVac N.V.
CVAC
|
-7.74 | - | - | $ 867 M | Germany |
 |
Acer Therapeutics
ACER
|
-3.39 | - | 2.71 % | $ 14 M | USA |
 |
Alpine Immune Sciences
ALPN
|
-5.5 | - | - | $ 2.17 B | USA |